cholecystokinin 9 has been researched along with aspartic acid in 3 studies
| Studies (cholecystokinin 9) | Trials (cholecystokinin 9) | Recent Studies (post-2010) (cholecystokinin 9) | Studies (aspartic acid) | Trials (aspartic acid) | Recent Studies (post-2010) (aspartic acid) |
|---|---|---|---|---|---|
| 23 | 1 | 3 | 23,005 | 417 | 4,018 |
| Protein | Taxonomy | cholecystokinin 9 (IC50) | aspartic acid (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 1.638 | |
| Excitatory amino acid transporter 1 | Homo sapiens (human) | 90.1265 | |
| Excitatory amino acid transporter 2 | Homo sapiens (human) | 11 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 1.638 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dufour, MN; Fourmy, D; Galés, C; Kowalski-Chauvel, A; Moroder, L; Pradayrol, L; Seva, C; Silvente-Poirot, S; Vaysse, N | 1 |
| Buyse, J; Cokelaere, M; De Cuyper, M; León-Tamariz, F; Pottel, H; Van Boven, M; Verbaeys, I | 1 |
| Cokelaere, M; Decuypere, E; León-Tamariz, F; Pottel, H; Swennen, Q; Verbaeys, I | 1 |
3 other study(ies) available for cholecystokinin 9 and aspartic acid
| Article | Year |
|---|---|
Mutation of Asn-391 within the conserved NPXXY motif of the cholecystokinin B receptor abolishes Gq protein activation without affecting its association with the receptor.
Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Asparagine; Aspartic Acid; Binding Sites; Cholecystokinin; Conserved Sequence; COS Cells; GTP-Binding Protein alpha Subunits, Gq-G11; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Inositol Phosphates; Mitogen-Activated Protein Kinases; Mutagenesis, Site-Directed; Peptide Fragments; Protein Kinase C; Rats; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Recombinant Proteins; Transfection; Type C Phospholipases | 2000 |
PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement.
Topics: Animals; Anorexia; Appetite Depressants; Aspartic Acid; Blood-Brain Barrier; Cholecystokinin; Delayed-Action Preparations; Devazepide; Dose-Response Relationship, Drug; Eating; Injections, Intraperitoneal; Male; Naphthalenesulfonates; Peptide Fragments; Polyethylene Glycols; Rats; Rats, Wistar; Receptor, Cholecystokinin A; Satiation | 2007 |
PEGylated cholecystokinin is more potent in inducing anorexia than conditioned taste aversion in rats.
Topics: Animals; Anorexia; Aspartic Acid; Avoidance Learning; Cholecystokinin; Devazepide; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Naphthalenesulfonates; Peptide Fragments; Polyethylene Glycols; Rats; Rats, Wistar; Receptor, Cholecystokinin A; Saccharin; Satiety Response; Taste | 2008 |